TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.16) by 118.75 percent. This is a 107.69 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $8.899 million which missed the analyst consensus estimate of $10.440 million by 14.76 percent. This is a 2.92 percent decrease over sales of $9.167 million the same period last year.